DURECT Corp

NASDAQ:DRRXUnited States

May 13, 2024

Show headlines and story abstract

• -- Earnings Flash (DRRX) DURECT CORPORATION Reports Q1 Revenue $1.8M, vs. Street Est of $2.7M, from 4:08PM ET on Monday May 13, 2024 by MT Newswires

  4:08PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: DRRX
  04:08 PM EDT, 05/13/2024 (MT Newswires) -- ...

• DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update, from 4:05PM ET on Monday May 13, 2024 by PR Newswire

  4:05PM ET on Monday May 13, 2024 by PR Newswire
  Companies Mentioned: DRRX

  FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis

  Webcast of Earnings Call Today, May 13th at 4:30 p.m. ET

  DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March 31, 2024 and provided a business update.

• DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update, from 4:05PM ET on Monday May 13, 2024 by Dow Jones

  4:05PM ET on Monday May 13, 2024 by Dow Jones
  Companies Mentioned: DRRX
  
  resources, our anticipated capital requirements, our need or desire for additional financing, our ability to continue to meet the minimum bid price for continued listing on Nasdaq, our ability to obtain capital to fund our operations and expenses, and our ability to continue to operate as a going concern. Further information regarding these and other risks is included in DURECT's most recent Securities and Exchange Commission (SEC) filings, including its annual report on Form 10-K for the year ended December 31, 2023 and quarterly report on Form 10-Q for the quarter ended March 31, 2024, when filed, under the heading "Risk Factors." These reports are available on our website www.durect.com under the "Investors" tab and on the SEC's website at www.sec.gov. All information provided in this press release and in the attachments is based on information available to DURECT as of the date hereof, and DURECT assumes no obligation to update this information as a result of future events or developments, except as required by law.
  

• *DJ Durect 1Q Loss/Shr 25c >DRRX, from 4:05PM ET on Monday May 13, 2024 by Dow Jones

  4:05PM ET on Monday May 13, 2024 by Dow Jones
  Companies Mentioned: DRRX
  
  resources, our anticipated capital requirements, our need or desire for additional financing, our ability to continue to meet the minimum bid price for continued listing on Nasdaq, our ability to obtain capital to fund our operations and expenses, and our ability to continue to operate as a going concern. Further information regarding these and other risks is included in DURECT's most recent Securities and Exchange Commission (SEC) filings, including its annual report on Form 10-K for the year ended December 31, 2023 and quarterly report on Form 10-Q for the quarter ended March 31, 2024, when filed, under the heading "Risk Factors." These reports are available on our website www.durect.com under the "Investors" tab and on the SEC's website at www.sec.gov. All information provided in this press release and in the attachments is based on information available to DURECT as of the date hereof, and DURECT assumes no obligation to update this information as a result of future events or developments, except as required by law.